Leukotrienes and Prostaglandins Mutually Govern the Antitumor Potential of Macrophages
- 1 January 1987
- book chapter
- Published by Springer Nature in Proceedings in Life Sciences
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Cyclooxygenase inhibitors promote the leukotriene C4 induced release of β-glucuronidase from rat peritoneal macrophages: Prostaglandin E2 suppressesInternational Journal of Immunopharmacology, 1986
- Products of the lipoxygenase pathway in human natural killer cell cytotoxicityCellular Immunology, 1985
- Cyclic AMP levels and their regulation by prostaglandins in peritoneal macrophages of rats and humansInternational Journal of Immunopharmacology, 1984
- Reactive oxygen production, arachidonate metabolism and cyclic AMP in macrophagesBiochemical and Biophysical Research Communications, 1983
- Effect of leukotriene C4 on the release of secretory products by elicited populations of rat peritoneal macrophagesEuropean Journal of Pharmacology, 1983
- Synthesis of leukotriene C and other arachidonic acid metabolites by mouse pulmonary macrophages.The Journal of Experimental Medicine, 1982
- Relationship of the suppression of macrophage mediated tumor cytotoxicity in conjunction with secretion of prostaglandin from the macrophages of breast cancer patientsInternational Journal of Immunopharmacology, 1982
- Prevention of macrophage tumoricidal activity by agents known to increase cellular cyclic AMPCellular Immunology, 1979
- Adaptation of murine MOPC-315 myeloma cells to growth in vitro and further characterization of their C-type virusesPublished by Elsevier ,1978
- Activated macrophages kill tumour cells by releasing arginaseNature, 1978